Literature DB >> 12056572

Characterization of lipooligosaccharides from Haemophilus ducreyi containing polylactosamine repeats.

Birgit Schilling1, Bradford W Gibson, Melanie Filiatrault, Anthony A Campagnari.   

Abstract

Haemophilus ducreyi, a gram-negative human mucosal pathogen, is one of the principal causes of genital ulcer disease. The lipooligosaccharides (LOS) of these bacteria are considered to be a major virulence factor and have been implicated in the adherence and invasion of H. ducreyi to several human cell types. An isogenic heptosyltransferase-III knockout strain (waaQ) was recently constructed from H. ducreyi 35000 wild-type strain and immunochemical and molecular weight data of the isolated LOS suggested the presence of poly-N-acetyllactosamine (LacNAc) (Filiatrault et al., Infect. Immun. 2000, 68, 3352-3361). In this present study, the structures of these novel LOS-glycoforms were characterized by matrix-assisted laser desorption/ionization (MALDI) and electrospray ionization (ESI) mass spectrometry in combination with exoglycosidase digestion. Detailed structural information was obtained for the oligosaccharide (OS) portions of these LOS showing between one to five linear LacNAc repeats on the non-reducing terminus of the main oligosaccharide branch. When grown on solid media, the organism produced LacNAc repeats that were further modified by the addition of sialic acid. Enzymatic digestion with beta-galactosidase, beta-N-acetylhexosaminidase, and neuraminidase type VI-A yielded truncated glycoforms consistent with a polyLacNAc structure capped at various end points with sialic acid. ESI-MS/MS mass spectrometry on a quadrupole time-of-flight instrument was particularly effective in obtaining detailed structural information on the least abundant, high-mass glycoforms. Although LOS containing terminal di-LacNAc have been reported, this is the first time to our knowledge that a linear polyLacNAc structure has been characterized in bacteria.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12056572     DOI: 10.1016/S1044-0305(02)00375-6

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  34 in total

Review 1.  The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi.

Authors:  C A Ison; J A Dillon; J W Tapsall
Journal:  Lancet       Date:  1998       Impact factor: 79.321

2.  Haemophilus ducreyi produces a novel sialyltransferase. Identification of the sialyltransferase gene and construction of mutants deficient in the production of the sialic acid-containing glycoform of the lipooligosaccharide.

Authors:  J A Bozue; M V Tullius; J Wang; B W Gibson; R S Munson
Journal:  J Biol Chem       Date:  1999-02-12       Impact factor: 5.157

3.  Mass spectrometric analysis of Klebsiella pneumoniae ssp. pneumoniae rough strain R20 (O1-: K20-) lipopolysaccharide preparations: identification of novel core oligosaccharide components and three 3-deoxy-D-manno-oct-2-ulopyranosonic artifacts.

Authors:  M M Olsthoorn; J Haverkamp; J E Thomas-Oates
Journal:  J Mass Spectrom       Date:  1999-06       Impact factor: 1.982

4.  Increased substitution of phosphate groups in lipopolysaccharides and lipid A of polymyxin-resistant mutants of Salmonella typhimurium and Escherichia coli.

Authors:  I M Helander; K Nummila; I Kilpeläinen; M Vaara
Journal:  Prog Clin Biol Res       Date:  1995

5.  Improved techniques for the preparation of bacterial lipopolysaccharides.

Authors:  K G Johnson; M B Perry
Journal:  Can J Microbiol       Date:  1976-01       Impact factor: 2.419

Review 6.  Isolation and characterization of lipopolysaccharides, lipooligosaccharides, and lipid A.

Authors:  M A Apicella; J M Griffiss; H Schneider
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

7.  Construction and characterization of Haemophilus ducreyi lipooligosaccharide (LOS) mutants defective in expression of heptosyltransferase III and beta1,4-glucosyltransferase: identification of LOS glycoforms containing lactosamine repeats.

Authors:  M J Filiatrault; B W Gibson; B Schilling; S Sun; R S Munson; A A Campagnari
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  Sequencing complex polysaccharides.

Authors:  G Venkataraman; Z Shriver; R Raman; R Sasisekharan
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

9.  Expression of human H-type alpha1,2-fucosyltransferase encoding for blood group H(O) antigen in Chinese hamster ovary cells. Evidence for preferential fucosylation and truncation of polylactosamine sequences.

Authors:  P A Prieto; R D Larsen; M Cho; H N Rivera; A Shilatifard; J B Lowe; R D Cummings; D F Smith
Journal:  J Biol Chem       Date:  1997-01-24       Impact factor: 5.157

10.  Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men.

Authors:  H Schneider; J M Griffiss; J W Boslego; P J Hitchcock; K M Zahos; M A Apicella
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  1 in total

1.  Structural characterization of an oligosaccharide made by Neisseria sicca.

Authors:  Ellen T O'Connor; Hui Zhou; Kevin Bullock; Karen V Swanson; J McLeod Griffiss; Vernon N Reinhold; Clinton J Miller; Daniel C Stein
Journal:  J Bacteriol       Date:  2009-03-06       Impact factor: 3.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.